We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

58 hedge funds and large institutions have $22.5M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $192K | Put options by funds: $32K

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

3% less funds holding

Funds holding: 60 → 58 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

32% less capital invested

Capital invested by funds: $32.8M → $22.5M (-$10.3M)

Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
21
Reduced
7
Closed
8
Calls
$192K
Puts
$32K
Net Calls
+$160K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
+$1.82M
2
AI
Ariel Investments
Illinois
+$499K
3
Renaissance Technologies
Renaissance Technologies
New York
+$279K
4
Morgan Stanley
Morgan Stanley
New York
+$263K
5
Deutsche Bank
Deutsche Bank
Germany
+$248K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$4.4M
2
GPP
Great Point Partners
Connecticut
-$800K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$470K
4
BFA
BlackRock Fund Advisors
California
-$211K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$154K
Name Holding Trade Value Shares
Change 		Change in
Stake
HK
26
Horizon Kinetics
New York
$59K – – –
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$51K – – –
CCMH
28
Cornerstone Capital Management Holdings
New York
$50K -$18.8K -6 -21%
EAM
29
Evanson Asset Management
California
$44K – – –
ARTA
30
A.R.T. Advisors
New York
$43K +$62.7K +20 New
Citigroup
31
Citigroup
New York
$38K -$25.1K -8 -32%
UBS Group
32
UBS Group
Switzerland
$36K +$34.5K +11 +183%
State Street
33
State Street
Massachusetts
$27K -$6.27K -2 -14%
BMM
34
Berkshire Money Management
Massachusetts
$26K – – –
Charles Schwab
35
Charles Schwab
California
$25K – – –
BA
36
BlackRock Advisors
Delaware
$21K – – –
EWM
37
Evercore Wealth Management
New York
$18K – – –
SW
38
SVB Wealth
Massachusetts
$18K – – –
Wells Fargo
39
Wells Fargo
California
$15K +$3.14K +1 +17%
Bank of America
40
Bank of America
North Carolina
$15K +$15.7K +5 +250%
FNT
41
First National Trust
Pennsylvania
$14K – – –
NFA
42
Nationwide Fund Advisors
Ohio
$14K – – –
PPSG
43
Princeton Portfolio Strategies Group
New Jersey
$12K – – –
WEC
44
Winslow Evans & Crocker
Massachusetts
$11.1K – – –
Millennium Management
45
Millennium Management
New York
$9K -$12.5K -4 -50%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$9K +$12.5K +4 New
BMO
47
Beck Mack & Oliver
New York
$8K – – –
GC
48
Guggenheim Capital
Illinois
$8K – – –
JIC
49
Joel Isaacson & Co
New York
$8K – – –
CS
50
Credit Suisse
Switzerland
$8K +$12.5K +4 New
1
2
3

FRTX Hedge Fund Activity: Q2 2015 in Review

58 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2015, worth a combined $22.5M — down 32% from $32.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FRTX and 7 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 21 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $1.82M. The largest seller was RA Capital Management, cutting an estimated $4.4M.

  • 58 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2015, down from 60 in Q1 2015.
  • Funds reported $22.5M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2015, down 32% quarter-over-quarter.
  • 7 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2015 and 8 closed out, a net change of -1 holder.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2015 was Rock Springs Capital Management, an estimated $1.82M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2015 was RA Capital Management, an estimated $4.4M sold.

Based on aggregated 13F filings for Q2 2015.